Neural computing in pharmaceutical products and process development

Abstract: This chapter presents a review of the possible applications of methods based on neural computing in pharmaceutical products and process development. Some of the methods described are used for classification purposes, whereas others can be applied to modeling and optimization, or even induction of rules. Basic concepts of each method are theoretically described, followed by examples of their application in pharmaceutical technology. A theoretical background aims to provide a better understanding of the methods and is based upon their most important features. Examples should encourage the reader to embrace the above-mentioned methods and use them to complement conventional statistical methods for classification and regression.

[1]  M. Khan,et al.  Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. , 2002, International journal of pharmaceutics.

[2]  Barry J. Wythoff,et al.  Backpropagation neural networks , 1993 .

[3]  J. Parojčić,et al.  Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  K. Kachrimanis,et al.  Artificial neural networks (ANNs) and modeling of powder flow. , 2003, International journal of pharmaceutics.

[5]  David M. Skapura,et al.  Neural networks - algorithms, applications, and programming techniques , 1991, Computation and neural systems series.

[6]  D. Coomans,et al.  Exploration of linear modelling techniques and their combination with multivariate adaptive regression splines to predict gastro-intestinal absorption of drugs. , 2007, Journal of pharmaceutical and biomedical analysis.

[7]  Johann Gasteiger,et al.  Self-organizing maps for identification of new inhibitors of P-glycoprotein. , 2007, Journal of medicinal chemistry.

[8]  Jaroslaw Polanski,et al.  Self-organizing neural networks for pharmacophore mapping. , 2003, Advanced drug delivery reviews.

[9]  Eytan Domany,et al.  Resampling Method for Unsupervised Estimation of Cluster Validity , 2001, Neural Computation.

[10]  Amiram Goldblum,et al.  Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[12]  C. Malsburg,et al.  How patterned neural connections can be set up by self-organization , 1976, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[13]  Yixin Chen,et al.  Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.

[14]  K. Kachrimanis,et al.  Flow rate of some pharmaceutical diluents through die-orifices relevant to mini-tableting. , 2005, International journal of pharmaceutics.

[15]  Hyunah Choo,et al.  Classification of dopamine, serotonin, and dual antagonists by decision trees. , 2006, Bioorganic & medicinal chemistry.

[16]  H. Kubinyi.  Variable Selection in QSAR Studies. II. A Highly Efficient Combination of Systematic Search and Evolution , 1994 .

[17]  Tijana Mihajlovic,et al.  Application of Design of Experiments and Multilayer Perceptron Neural Network in Optimization of the Spray-Drying Process , 2011 .

[18]  P. M. Dean,et al.  Molecular Similarity in Drug Design , 2007 .

[19]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[20]  Euntai Kim,et al.  A new approach to fuzzy modeling , 1997, IEEE Trans. Fuzzy Syst..

[21]  Svetlana Ibrić,et al.  Analysis of fluidized bed granulation process using conventional and novel modeling techniques. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Peter Wolschann,et al.  Validation of fluid bed granulation utilizing artificial neural network. , 2005, International journal of pharmaceutics.

[23]  Christel C. Müller-Goymann,et al.  Fitting of diffusion coefficients in a three-compartment sustained release drug formulation using a genetic algorithm , 1995 .

[24]  John Elder,et al.  Handbook of Statistical Analysis and Data Mining Applications , 2009 .

[25]  James Devillers,et al.  Neural Networks in QSAR and Drug Design , 1996 .

[26]  R. C. Rowe,et al.  AN EXPERT SYSTEM FOR THE IDENTIFICATION AND SOLUTION OF FILM-COATING DEFECTS , 1993 .

[27]  Q Shao,et al.  Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  Hiroaki Arai,et al.  Creation of a tablet database containing several active ingredients and prediction of their pharmaceutical characteristics based on ensemble artificial neural networks. , 2010, Journal of pharmaceutical sciences.

[29]  Simon Haykin,et al.  Neural Networks: A Comprehensive Foundation , 1998 .

[30]  Rasit Köker,et al.  Design and performance of an intelligent predictive controller for a six-degree-of-freedom robot using the Elman network , 2006, Inf. Sci..

[31]  Jonathan Seville,et al.  Using intelligent software to predict the effects of formulation and processing parameters on roller compaction , 2008 .

[32]  Michael Q. Zhang,et al.  Evaluation and comparison of clustering algorithms in analyzing es cell gene expression data , 2002 .

[33]  Kozo Takayama,et al.  Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.

[34]  Geoffrey E. Hinton,et al.  Learning internal representations by error propagation , 1986 .

[35]  Donald F. Specht,et al.  A general regression neural network , 1991, IEEE Trans. Neural Networks.

[36]  L. P. J. Veelenturf,et al.  Analysis and applications of artificial neural networks , 1995 .

[37]  Teuvo Kohonen,et al.  Self-Organizing Maps , 2010 .

[38]  Peter York,et al.  The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  Sampsa Laine,et al.  Visualization of particle size and shape distributions using self-organizing maps , 2002 .

[40]  Tamás D. Gedeon,et al.  Improvements in Sugeno-Yasukawa modelling algorithm , 2010, International Conference on Fuzzy Systems.

[41]  S. Agatonovic-Kustrin,et al.  Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation. , 2008, International journal of pharmaceutics.

[43]  Leah L. Rogers,et al.  Solving Problems in Environmental Engineering and Geosciences with Artificial Neural Networks , 1996 .

[44]  Athanasios Tsakonas,et al.  Symbolic regression via genetic programming in the optimization of a controlled release pharmaceutical formulation , 2011 .

[45]  Svetlana Ibrić,et al.  Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Juan R. Rabuñal,et al.  Artificial Neural Networks in Real-Life Applications , 2005 .

[47]  X. Wu,et al.  Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  B. Yegnanarayana,et al.  Artificial Neural Networks , 2004 .

[49]  Helge Ritter,et al.  Self-organizing feature maps: Kohonen maps , 1998 .

[50]  S. Ibrić,et al.  The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems. , 2008, International journal of pharmaceutics.

[51]  M C Meyer,et al.  The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Y. Onuki,et al.  Reliability evaluation of the design space of the granulation process of mefenamic acid tablets using a bootstrap resampling technique. , 2011, Chemical & pharmaceutical bulletin.

[53]  Chee Peng Lim,et al.  Use of Artificial Neural Networks to Predict Drug Dissolution Profiles and Evaluation of Network Performance Using Similarity Factor , 2000, Pharmaceutical Research.

[54]  Herbert Moskowitz,et al.  Machine learning and genetic algorithms in pharmaceutical development and manufacturing processes , 2009, Decis. Support Syst..

[55]  R. Erb,et al.  Introduction to Backpropagation Neural Network Computation , 1993, Pharmaceutical Research.

[56]  F ROSENBLATT,et al.  The perceptron: a probabilistic model for information storage and organization in the brain. , 1958, Psychological review.

[57]  Marco Pintore,et al.  Prediction of oral bioavailability by adaptive fuzzy partitioning. , 2003, European journal of medicinal chemistry.

[58]  M Tusar,et al.  Viscosity prediction of lipophilic semisolid emulsion systems by neural network modelling. , 2000, International journal of pharmaceutics.

[59]  James L. McClelland.  Explorations In Parallel Distributed Processing , 1988 .

[60]  Alexander Klenner,et al.  'Fuzziness' in pharmacophore-based virtual screening and de novo design. , 2010, Drug discovery today. Technologies.

[61]  José M. Aragón,et al.  Designing and Optimizing a Neural Network for the Modeling of a Fluidized-Bed Drying Process , 2002 .

[62]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[63]  Johann Gasteiger,et al.  Explorations into modeling human oral bioavailability. , 2008, European journal of medicinal chemistry.

[64]  Franc Vrecer,et al.  Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network , 1997 .

[65]  Etienne E. Kerre,et al.  Defuzzification: criteria and classification , 1999, Fuzzy Sets Syst..

[66]  K. Leiviskä,et al.  The advantages by the use of neural networks in modelling the fluidized bed granulation process , 1994 .

[67]  Svetlana Ibrić,et al.  Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees. , 2012, International journal of pharmaceutics.

[68]  Robert D. Johnson,et al.  Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.

[69]  Madan M. Gupta,et al.  Static and Dynamic Neural Networks: From Fundamentals to Advanced Theory , 2003 .

[70]  T. Rades,et al.  Use of artificial neural networks to predict quaternery phase systems from limited experimental data. , 1999, Journal of pharmaceutical and biomedical analysis.

[71]  D. Broomhead,et al.  Radial Basis Functions, Multi-Variable Functional Interpolation and Adaptive Networks , 1988 .

[72]  Yugyung Lee,et al.  Assessment of diffusion coefficient from mucoadhesive barrier devices using artificial neural networks. , 2008, International journal of pharmaceutics.

[73]  J. Ross Quinlan,et al.  C4.5: Programs for Machine Learning , 1992 .

[74]  Francis J. Doyle,et al.  A dynamic neural network approach to nonlinear process modeling , 1997 .

[75]  D. Walters,et al.  Genetically evolved receptor models: a computational approach to construction of receptor models. , 1994, Journal of medicinal chemistry.

[76]  T Nagai,et al.  Formula optimization based on artificial neural networks in transdermal drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[77]  Rajarshi Guha,et al.  Generation of QSAR sets with a self-organizing map. , 2004, Journal of molecular graphics & modelling.

[78]  Svetlana Ibrić,et al.  The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[79]  A Philip Plumb,et al.  A decision-support tool for the formulation of orally active, poorly soluble compounds. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[80]  Chee Peng Lim,et al.  Prediction of drug release profiles using an intelligent learning system: an experimental study in transdermal iontophoresis. , 2003, Journal of pharmaceutical and biomedical analysis.

[81]  A. Woolfson,et al.  Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: optimisation by an artificial neural network. , 2010, International journal of pharmaceutics.

[82]  J. Rantanen,et al.  Visualization of fluid-bed granulation with self-organizing maps. , 2001, Journal of pharmaceutical and biomedical analysis.

[83]  K. Jayaram Kumar,et al.  An adaptive neuro-fuzzy inference system for optimising the emulsifier concentration in the formulation of an O/W emulsion , 2010 .

[84]  Svetlana Ibrić,et al.  Design Space Approach in Optimization of Fluid Bed Granulation and Tablets Compression Process , 2012, TheScientificWorldJournal.

[85]  H Schmidli,et al.  Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[86]  J A Dowell,et al.  Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience. , 1999, Journal of pharmaceutical sciences.

[87]  Ronald R. Yager,et al.  Essentials of fuzzy modeling and control , 1994 .

[88]  Anil K. Jain,et al.  Data clustering: a review , 1999, CSUR.

[89]  E. H. Mamdani,et al.  Advances in the linguistic synthesis of fuzzy controllers , 1976 .

[90]  Rowe,et al.  Neuro-fuzzy logic in tablet film coating formulation. , 1999, Pharmaceutical science & technology today.

[91]  Nam Sook Kang,et al.  Classification models for CYP450 3A4 inhibitors and non-inhibitors. , 2009, European journal of medicinal chemistry.

[92]  Q Shao,et al.  Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[93]  Yoshinori Onuki,et al.  Latent structure analysis in pharmaceutical formulations using Kohonen's self-organizing map and a Bayesian network. , 2011, Journal of pharmaceutical sciences.

[94]  George Cybenko,et al.  Approximation by superpositions of a sigmoidal function , 1992, Math. Control. Signals Syst..

[95]  H. Chrystyn,et al.  Determination of factors controlling the particle size in nanoemulsions using Artificial Neural Networks. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[96]  Brian Samas,et al.  An intravenous formulation decision tree for discovery compound formulation development. , 2003, International journal of pharmaceutics.

[97]  Wei-Ke Lv,et al.  Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods. , 2010, European journal of medicinal chemistry.

[98]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[99]  P. Khadikar,et al.  Prediction of intrinsic solubility of generic drugs using MLR, ANN and SVM analyses. , 2010, European journal of medicinal chemistry.

[100]  Marc Toussaint,et al.  Extracting Motion Primitives from Natural Handwriting Data , 2006, ICANN.

[101]  Kei Miyanami,et al.  Image processing for on-line monitoring of granule size distribution and shape in fluidized bed granulation , 1995 .

[102]  Michael C Hutter,et al.  Determination of hERG channel blockers using a decision tree. , 2006, Bioorganic & medicinal chemistry.

[103]  Kevin N. Gurney,et al.  An introduction to neural networks , 2018 .

[104]  Hisao Ishibuchi,et al.  Selecting fuzzy if-then rules for classification problems using genetic algorithms , 1995, IEEE Trans. Fuzzy Syst..

[105]  Teuvo Kohonen,et al.  Self-Organization and Associative Memory , 1988 .

[106]  José A. Romagnoli,et al.  On the topological modeling and analysis of industrial process data using the SOM , 2010, Comput. Chem. Eng..

[107]  Kei Miyanami,et al.  Control Granule Growth in Fluidized Bed Granulation by an Image Processing System , 1996 .

[108]  Chee Peng Lim,et al.  Application of a Recurrent Neural Network to Prediction of Drug Dissolution Profiles , 2002, Neural Computing & Applications.

[109]  T Sovány,et al.  Modeling of subdivision of scored tablets with the application of artificial neural networks. , 2010, Journal of pharmaceutical sciences.

[110]  Y. Obata,et al.  A statistical approach to the development of a transdermal delivery system for ondansetron. , 2010, International journal of pharmaceutics.

[111]  S. Inghelbrecht.  Instrumentation of a roll compactor and the evaluation of the parameter settings by neural networks , 1997 .

[112]  D. Manallack,et al.  Neural networks in drug discovery: Have they lived up to their promise? , 1999 .

[113]  Takeshi Yamakawa,et al.  Learning of SOR network employing soft-max adaptation rule of neural gas network , 2006 .

[114]  Hagar I Labouta,et al.  Multivariate modeling of encapsulation and release of an ionizable drug from polymer microspheres. , 2009, Journal of pharmaceutical sciences.

[115]  S. Agatonovic-Kustrin,et al.  Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.

[116]  Bin Wang,et al.  Application of GA-RBF networks to the nondestructive determination of active component in pharmaceutical powder by NIR spectroscopy , 2009 .

[117]  Anthony Zaknich,et al.  Neural Networks for Intelligent Signal Processing , 2003, Series on Innovative Intelligence.

[118]  Palma Blonda,et al.  A survey of fuzzy clustering algorithms for pattern recognition. I , 1999, IEEE Trans. Syst. Man Cybern. Part B.

[119]  Venkat Venkatasubramanian,et al.  Computer-aided molecular design using genetic algorithms , 1994 .

[120]  Beth A Sproule,et al.  Fuzzy pharmacology: theory and applications. , 2002, Trends in pharmacological sciences.

[121]  Christopher T. Rhodes,et al.  Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .

[122]  Philipp Slusallek,et al.  Introduction to real-time ray tracing , 2005, SIGGRAPH Courses.

[123]  Teuvo Kohonen,et al.  The self-organizing map , 1990, Neurocomputing.

[124]  N. L. Solomun,et al.  In silico methods in stability testing of hydrocortisone, powder for injections: Multiple regression analysis versus dynamic neural network , 2012 .

[125]  Min Liang,et al.  Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs. , 2011, International journal of pharmaceutics.

[126]  David West,et al.  A comparison of SOM neural network and hierarchical clustering methods , 1996 .

[127]  James C. Bezdek,et al.  Pattern Recognition with Fuzzy Objective Function Algorithms , 1981, Advanced Applications in Pattern Recognition.

[128]  Mingjun Zhang,et al.  A genetic algorithm-based area coverage approach for controlled drug delivery using microrobots. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[129]  Daniel R. Fairbairn,et al.  Neural-network applications in predicting moment-curvature parameters from experimental data , 1996 .

[130]  Amir Amani,et al.  Artificial neural networks modelling the prednisolone nanoprecipitation in microfluidic reactors. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[131]  T Nagai,et al.  Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[132]  Hiroshi Ichikawa,et al.  Hierarchy neural networks as applied to pharmaceutical problems. , 2003, Advanced drug delivery reviews.

[133]  Sandhya Samarasinghe,et al.  Neural Networks for Applied Sciences and Engineering , 2006 .

[134]  Gisbert Schneider,et al.  Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps. , 2003, Journal of combinatorial chemistry.

[135]  Peter York,et al.  Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[136]  J. Zupan,et al.  Neural networks: A new method for solving chemical problems or just a passing phase? , 1991 .

[137]  Ernst R. Dow,et al.  Self-organizing maps for the analysis of NMR spectra , 2004 .

[138]  Gary W Slater,et al.  Combinatorial design of passive drug delivery platforms. , 2007, International journal of pharmaceutics.

[139]  Sirkka-Liisa Jämsä-Jounela,et al.  A process monitoring system based on the Kohonen self-organizing maps , 2003 .

[140]  Jakub Szlęk,et al.  Analysis of pellet properties with use of artificial neural networks. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[141]  Christophe G. Lambert,et al.  Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning , 1999, J. Chem. Inf. Comput. Sci..

[142]  Kozo Takayama,et al.  Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .

[143]  N K Ebube,et al.  Preformulation studies and characterization of the physicochemical properties of amorphous polymers using artificial neural networks. , 2000, International journal of pharmaceutics.

[144]  D C Plaut,et al.  Simulating brain damage. , 1993, Scientific American.

[145]  Lawrence J. Fogel,et al.  Artificial Intelligence through Simulated Evolution , 1966 .

[146]  R. Panerai,et al.  Neural network modelling of dynamic cerebral autoregulation: assessment and comparison with established methods. , 2004, Medical engineering & physics.

[147]  J. Ross Quinlan,et al.  Induction of Decision Trees , 1986, Machine Learning.

[148]  David Haussler,et al.  What Size Net Gives Valid Generalization? , 1989, Neural Computation.

[149]  Subbarao Kambhampati,et al.  Evolutionary Computing , 1997, Lecture Notes in Computer Science.

[150]  Self-organizing map analysis using multivariate data from theophylline powders predicted by a thin-plate spline interpolation. , 2010, Journal of pharmaceutical sciences.

[151]  D. Dazzi,et al.  The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method. , 2001, Journal of diabetes and its complications.

[152]  J. Ross Quinlan,et al.  Improved Use of Continuous Attributes in C4.5 , 1996, J. Artif. Intell. Res..

[153]  Dimitrios Kalles,et al.  Breeding Decision Trees Using Evolutionary Techniques , 2001, ICML.

[154]  Gérard Dreyfus,et al.  Neural networks - methodology and applications , 2005 .

[155]  Andrew A. Goldenberg,et al.  Development of a systematic methodology of fuzzy logic modeling , 1998, IEEE Trans. Fuzzy Syst..

[156]  Earl Cox,et al.  The fuzzy systems handbook - a practitioner's guide to building, using, and maintaining fuzzy systems , 1994 .

[157]  Carl G. Looney,et al.  Advances in Feedforward Neural Networks: Demystifying Knowledge Acquiring Black Boxes , 1996, IEEE Trans. Knowl. Data Eng..

[158]  Michio Sugeno,et al.  A fuzzy-logic-based approach to qualitative modeling , 1993, IEEE Trans. Fuzzy Syst..

[159]  Marcus A A Reis,et al.  An alternative approach based on artificial neural networks to study controlled drug release. , 2004, Journal of pharmaceutical sciences.

[160]  I A Basheer,et al.  Artificial neural networks: fundamentals, computing, design, and application. , 2000, Journal of microbiological methods.

[161]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[162]  J. Gasteiger,et al.  Knowledge Discovery in Reaction Databases: Landscaping Organic Reactions by a Self-Organizing Neural Network , 1997 .

[163]  Marcel de Matas,et al.  Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[164]  Kozo Takayama,et al.  Neural network based optimization of drug formulations. , 2003, Advanced drug delivery reviews.

[165]  Svetlana Ibrić,et al.  An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[166]  Christopher M. Bishop,et al.  Neural networks for pattern recognition , 1995 .

[167]  V. J. Rayward-Smith,et al.  Fuzzy Cluster Analysis: Methods for Classification, Data Analysis and Image Recognition , 1999 .

[168]  A. Zbinden,et al.  Arterial pressure control with isoflurane using fuzzy logic. , 1995, British journal of anaesthesia.

[169]  Svetlana Ibric,et al.  Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN) , 2010, Archives of pharmacal research.

[170]  Brian J. Taylor,et al.  Methods and Procedures for the Verification and Validation of Artificial Neural Networks , 2005 .

[171]  Alejandro C Olivieri,et al.  Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks. , 2009, International journal of pharmaceutics.

[172]  N. Mehrshad,et al.  Using a fuzzy controller optimized by a genetic algorithm to regulate blood glucose level in type 1 diabetes , 2011, Journal of medical engineering & technology.

[173]  Ovidiu Ivanciuc,et al.  Applications of Support Vector Machines in Chemistry , 2007 .

[174]  K. Nakakimura,et al.  Hypertension control during anesthesia. Fuzzy logic regulation of nicardipine infusion , 1994, IEEE Engineering in Medicine and Biology Magazine.